StockData
Nexalin Technology, Inc. logo

Nexalin Technology, Inc. (NXL) stock

NXLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$1.44−0.06 (-4.00%)

Close on Nov 18, 2026Market cap $31.73MP/E –Yield –

Nexalin Technology enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Nexalin Technology's enterprise value was $33.98M on Nov 11, 2026, against $585.05M a year earlier. Over the last 4 years it ranged from $33.98M to $1.61B, with a median of $208.83M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$33.98M-88.7%
2025Dec 31, 2025$300.17M-71.7%
2024Dec 31, 2024$1.06B+1165.5%
2023Dec 29, 2023$83.80M-46.2%
2022Dec 30, 2022$155.73M–

More Nexalin Technology figures

See a number that looks wrong?